CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 205 filers reported holding CHEMOCENTRYX INC in Q3 2020. The put-call ratio across all filers is 0.50 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $2,879,000 | +108.8% | 79,076 | -1.9% | 0.00% | +100.0% |
Q3 2021 | $1,379,000 | +8.8% | 80,631 | -14.8% | 0.00% | 0.0% |
Q2 2021 | $1,267,000 | -59.4% | 94,605 | +55.5% | 0.00% | -60.0% |
Q1 2021 | $3,117,000 | -17.2% | 60,827 | 0.0% | 0.01% | -28.6% |
Q4 2020 | $3,766,000 | +12.6% | 60,827 | -0.3% | 0.01% | 0.0% |
Q3 2020 | $3,344,000 | -4.5% | 61,021 | +0.3% | 0.01% | -12.5% |
Q2 2020 | $3,500,000 | +43.2% | 60,827 | 0.0% | 0.01% | +33.3% |
Q1 2020 | $2,444,000 | +1.6% | 60,827 | 0.0% | 0.01% | +20.0% |
Q4 2019 | $2,406,000 | – | 60,827 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tri Locum Partners LP | 545,532 | $13,518,000 | 5.54% |
Integral Health Asset Management, LLC | 574,029 | $14,224,000 | 2.93% |
HealthCor Management, L.P. | 1,097,370 | $27,193,000 | 2.73% |
Logos Global Management LP | 600,000 | $14,868,000 | 2.73% |
Cormorant Asset Management, LP | 1,425,000 | $35,312,000 | 2.67% |
Altium Capital Management LP | 160,000 | $3,965,000 | 1.59% |
Cahill Wealth Management, LLC | 68,358 | $1,693,000 | 1.43% |
Hood River Capital Management LLC | 1,336,776 | $33,125,000 | 1.32% |
Sofinnova Investments, Inc. | 636,659 | $15,776,000 | 1.31% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,000 | $121,100,000 | 1.26% |